CompuGroup Medical SE & Co. KGaA: Release of a capital market information

DGAP Post-admission Duties announcement: CompuGroup Medical SE & Co. KGaA / Share Buy-Back CompuGroup Medical SE & Co. KGaA: Release of a capital market information 19.04.2021 / 17:14 Dissemination of a Post-admission Duties announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. Disclosure pursuant to Art. 5 para. 1 lit. b) and para. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 para. 2 and para. 3 of the Commission Delegated Regulation (EU) No 2016/1052 CompuGroup Medical SE & Co. KGaA: Share Buy-Back Program - 7th Interim Announcement In the period from April 12, 2021 until and including April 16, 2021, CompuGroup Medical SE & Co. KGaA has bought back an aggregate number of 125,996 shares in CompuGroup Medical SE & Co. KGaA within its share buy-back program which had been announced on February 25, 2021 pursuant to Art. 2 para. 1 Commission Delegated Regulation (EU) No 2016/1052 to start on February 26, 2021 and which has been increased and extended as per announcement on March 25, 2021. The aggregate number of shares bought back each day during the period from April 12, 2021 until and including April 16, 2021 as well as the daily volume-weighted average prices for such buy-backs are as follows: Date Aggregate volume (number of no-par value shares) Volume-weighted average price (in EUR, excluding ancillary costs and charges) April 12, 2021 26,390 72.4946 April 13, 2021 25,586 73.9193 April 14, 2021 25,176 74.0630 April 15, 2021 24,732 74.0887 April 16, 2021 24,112 74.2085 Total: 125,996 73.7382   The aggregate number of shares bought back within the share buy-back program in the period from February 26, 2021 until and including April 16, 2021 amounts to 890,917 shares. Detailed information about the transactions are published on the company's website under www.cgm.com/sbb. The acquisitions of the shares in CompuGroup Medical SE & Co. KGaA were carried out by a credit institution assigned by CompuGroup Medical SE & Co. KGaA exclusively via the Frankfurt Stock Exchange (XETRA trading). Koblenz, April 19, 2021 CompuGroup Medical SE & Co. KGaA The general partner 19.04.2021 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

Language:	English
Company:	CompuGroup Medical SE & Co. KGaA
	Maria Trost 21
	56070 Koblenz
	Germany
Internet:	www.cgm.com

End of News	DGAP News Service

1186342  19.04.2021